Rocket One RKTO
NASDAQ RKTO
$0.37 -0.01 (-2.63%)
At close: Nov 11, 2026 · 4:00 PM EST

Rocket One (RKTO) Other Accumulated Expenses (2022)

Updated

Rocket One (RKTO) posted Other Accumulated Expenses of $50,000 for Q4 2022.

Analysis

Rocket One (RKTO) Other Accumulated Expenses (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Rocket One 8.81 Mn -17.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 50,000.00
API Access

Rocket One Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RKTO&period=max&api_key=YOUR_API_KEY